Research Notes
January 31, 2023
Impressive growth in FY22
December 22, 2022
Major license fee underpins full-year result
September 27, 2022
Another positive period for Instem
September 05, 2022
Largest ever contract validates growth strategy
August 04, 2022
H1 22 – Strong trading and positive outlook
April 26, 2022
FY21: Strong financial performance, strategic transformation
January 26, 2022
Trading in-line, all key metrics improving
September 28, 2021
Strong organic and acquisitive growth
September 01, 2021
A strategic move in Switzerland
July 19, 2021
H1 21 trading: strength across the board
April 12, 2021
FY 20A: Solid growth, despite COVID-19
March 22, 2021
Transformational deal in clinical trial analysis
March 01, 2021
Strengthening the position in Discovery
January 14, 2021
Strong end to 2020 – positioned for growth
September 28, 2020
Momentum remains strong
July 20, 2020
Strong trading, successful fundraise
June 03, 2020
Solid trading, strong delivery
March 25, 2020
Defensive in uncertain times
January 13, 2020
Firing On All Cylinders
November 18, 2019
Acquisition in Safety Assessment
October 16, 2019
Informatics in Focus
September 23, 2019
Building Momentum
July 15, 2019
SEND, SaaS and Strength of Pipeline
April 01, 2019
Another Year of Solid Delivery
January 22, 2019
All Business Areas Performing Well
View All Progressive Equity Research Notes